APD791

DRUG4 trials

Sponsors

Arena Pharmaceuticals, IlDong Pharmaceutical Co Ltd

Conditions

Acute Coronary SyndromeHealthy

Phase 1

Single-Dose Safety Study of APD791 in Healthy Volunteers

CompletedNCT00529646

Arena PharmaceuticalsHealthy

Start: 2007-07-31Target: 90Updated: 2008-12-30

A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

CompletedNCT00619931

Arena PharmaceuticalsHealthy

Start: 2008-01-31End: 2008-06-30Updated: 2022-07-05

Safety Study of APD-791 With Aspirin and/or Clopidogrel

TerminatedNCT02034292

IlDong Pharmaceutical Co LtdAcute Coronary Syndrome

Start: 2014-02-28End: 2014-03-31Updated: 2019-02-15

Dose-escalation, Repeated and Single Oral Dosing Study

TerminatedNCT02419820

IlDong Pharmaceutical Co LtdAcute Coronary Syndrome

Start: 2015-03-31End: 2016-04-30Updated: 2019-02-15